Biliary tract cancer--treatment options

Area of Science:

• Oncology
• Gastroenterology

Background:

• Extrahepatic biliary tract cancers are rare but present significant diagnostic and therapeutic challenges.
• Surgical resection is the primary curative treatment option.

Purpose of the Study:

• To review the diagnostic and therapeutic challenges of extrahepatic biliary tract cancers.
• To evaluate the efficacy of different treatment modalities.

Main Methods:

• Review of existing literature on surgical resection, bypass procedures, and adjuvant therapies.
• Analysis of resectability rates and survival outcomes based on tumor location.
• Assessment of morbidity and mortality associated with surgical interventions.

Main Results:

• Resectability rates range from 50% for lower common bile duct tumors to 10% for upper third tumors.
• Five-year survival rates are 20-30% for lower tumors and 10-15% for upper tumors.
• Bypass procedures have significant morbidity and mortality; endoscopic drainage is preferred.
• Radiotherapy and chemotherapy have shown limited efficacy, but combined intra-arterial chemotherapy and radiotherapy may offer benefits.

Conclusions:

• Surgical resection is crucial for cure, with outcomes dependent on tumor location.
• Palliative bypass and endoscopic drainage are important for symptom management.
• Further trials are needed to evaluate combined intra-arterial chemotherapy and radiotherapy.